GreenLight Biosciences (GRNA) Income Statement (2022 - 2023)
Income Statement report data from Mar 31, 2022 to Mar 31, 2023 for GreenLight Biosciences (GRNA).
Reported currency: USD
| Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | |
|---|---|---|---|---|---|
Revenue and COGS | |||||
Total Revenue | 3.82M (+26.49%) | 3.02M (+74.57%) | 1.73M (-2.26%) | 1.77M (+580.77%) | 260K |
Gross Profit | 3.82M (+26.49%) | 3.02M (+74.57%) | 1.73M (-2.26%) | 1.77M (+580.77%) | 260K |
Operating Expenses | |||||
Research And Development | 23M (-28.55%) | 32M (+8.32%) | 30M (-32.19%) | 44M (+61.84%) | 27M |
Selling General And Administrative | 8.94M (+4.32%) | 8.57M (+6.72%) | 8.03M (-16.18%) | 9.58M (-1.84%) | 9.76M |
Operating Expenses | 32M (-23.49%) | 42M (+10.53%) | 38M (-29.33%) | 54M (+45.06%) | 37M |
Operating Income | |||||
Operating Income | -28.29M (-27.35%) | -38.94M (+7.45%) | -36.24M (-30.25%) | -51.96M (+41.27%) | -36.78M |
EBITDA | -24.93M (-20.02%) | -31.17M (-9.60%) | -34.48M (-33.64%) | -51.96M (+57.22%) | -33.05M |
Other Income / Expenses | |||||
Interest Income | 600K (+1.69%) | 590K (+145.83%) | 240K (+300.00%) | 60K | - |
Interest Expense | -1.01M (+57.81%) | -640.00K (-40.19%) | -1.07M (-20.15%) | -1.34M (+25.23%) | -1.07M |
Net Interest Income | 1.61M (+29.84%) | 1.24M (-5.34%) | 1.31M (-6.43%) | 1.40M (+29.63%) | 1.08M |
Other Non Operating Income | 230K (0.00%) | 230K | - | 1.32M | -360.00K |
Net Income | |||||
Income Before Tax | -28.47M (-26.55%) | -38.76M (+4.56%) | -37.07M (-28.62%) | -51.93M (+35.91%) | -38.21M |
Income Tax Expense | - | - | 1.09M | - | - |
Net Income From Continuing Operations | -28.47M (-26.55%) | -38.76M (+1.57%) | -38.16M (-26.52%) | -51.93M (+35.91%) | -38.21M |
Net Income | -28.47M (-26.55%) | -38.76M (+1.57%) | -38.16M (-26.52%) | -51.93M (+35.91%) | -38.21M |